| Year |
Citation |
Score |
| 2018 |
Jiang YP, Liu BY, Zheng Q, Panuganti S, Chen R, Zhu J, Mishra M, Huang J, Dao-Pick T, Roy S, Zhao X, Lin J, Banik G, Hsi ED, Mandalam R, et al. CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia. Blood Advances. 2: 1738-1749. PMID 30037800 DOI: 10.1182/bloodadvances.2018020107 |
0.333 |
|
| 2013 |
Konieczna IM, Panuganti S, DeLuca TA, Papoutsakis ET, Eklund EA, Miller WM. Administration of nicotinamide does not increase platelet levels in mice. Blood Cells, Molecules & Diseases. 50: 171-6. PMID 23265740 DOI: 10.1016/J.Bcmd.2012.11.007 |
0.624 |
|
| 2013 |
Panuganti S, Schlinker AC, Lindholm PF, Papoutsakis ET, Miller WM. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Engineering. Part A. 19: 998-1014. PMID 23190353 DOI: 10.1089/Ten.Tea.2011.0111 |
0.6 |
|
| 2010 |
Panuganti S, Papoutsakis ET, Miller WM. Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential. Cytotherapy. 12: 767-82. PMID 20482285 DOI: 10.3109/14653241003786148 |
0.586 |
|
| 2008 |
Panuganti S, Papoutsakis ET, Miller WM. Nicotinamide increases the megakaryocytic maturation of human hematopoietic stem cells primarily due to sirtuin inhibition Aiche Annual Meeting, Conference Proceedings. DOI: 10.1182/Blood.V112.11.2445.2445 |
0.766 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Nishimoto KP, Barca T, Azameera A, Makkouk A, Romero JM, Bai L, Brodey MM, Kennedy-Wilde J, Shao H, Papaioannou S, Doan A, Masri C, Hoang NT, Tessman H, Ramanathan VD, ... ... Panuganti S, et al. Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models. Clinical & Translational Immunology. 11: e1373. PMID 35136603 DOI: 10.1002/cti2.1373 |
0.29 |
|
| 2018 |
Ravandi F, Abboud CN, Akard LP, Gill SI, Hsu JW, Kambhampati S, Khan I, Liu D, Stock W, Brown JW, Bashey A, Borthakur G, DiNardo CD, Holland HK, Kadia TM, ... ... Panuganti S, et al. Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy Blood. 132: 1407-1407. DOI: 10.1182/Blood-2018-99-117231 |
0.258 |
|
| 2009 |
Giammona LM, Panuganti S, Kemper JM, Apostolidis PA, Lindsey S, Papoutsakis ET, Miller WM. Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition. Experimental Hematology. 37: 1340-1352.e3. PMID 19715739 DOI: 10.1016/J.Exphem.2009.08.004 |
0.215 |
|
| 2021 |
Desai PM, Brown J, Gill S, Solh MM, Akard LP, Hsu JW, Ustun C, Andreadis C, Frankfurt O, Foran JM, Lister J, Schiller GJ, Wieduwilt MJ, Pagel JM, Stiff PJ, ... ... Panuganti S, et al. Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001739. PMID 34156898 DOI: 10.1200/JCO.20.01739 |
0.148 |
|
| 2004 |
Kosto KB, Panuganti S, Deen WM. Equilibrium partitioning of Ficoll in composite hydrogels. Journal of Colloid and Interface Science. 277: 404-9. PMID 15341852 DOI: 10.1016/J.Jcis.2004.04.063 |
0.114 |
|
| 2019 |
McMahon G, Panuganti S, Wilson M, Thaker T, Mueller T. Pulling the Foley: Can the prostatic urethral lift be used in men with catheter dependent urinary retention? European Urology Supplements. 18: e1504. DOI: 10.1016/S1569-9056(19)31084-X |
0.01 |
|
| Hide low-probability matches. |